Search for: "Michael C Price" Results 1 - 20 of 1,047
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Jan 2024, 10:24 am by Rebecca Tushnet
Thus, Michaels’ products are always available—in store and online—for at least 20% off the prices Michaels characterizes as “regular. [read post]
19 Dec 2016, 11:28 am by Kent Scheidegger
Michael Moore is an obnoxious jerk, but most of what he does is within the bounds that we must tolerate as the price of freedom of speech. [read post]
30 Nov 2022, 5:42 am by Michael Geist
The post Freedom of Expression for a Price: Government Confirms Bill C-18 Requires Platform Payment for User Posts That Include News Quotes and Hyperlinks appeared first on Michael Geist. [read post]
22 Sep 2023, 7:52 am by Michael Geist
The post Why the Government is Quietly Undermining Competition Bureau Independence in Bill C-56 appeared first on Michael Geist. [read post]
16 Jun 2023, 5:00 am by Michael Geist
The post The Bill C-11 Fallout Continues: Disney+ Pauses Original Commissions in Canada appeared first on Michael Geist. [read post]
9 Apr 2024, 3:00 am by John Jenkins
Otherwise, I’m at a loss to see where the fixed price offering requirement is provided by Rule 145(c). [read post]
20 Sep 2021, 6:05 am by Michael Geist
The digital policy issues that grabbed attention throughout the spring – Bill C-10, online harms, wireless pricing – were largely absent from the discussion and in some cases even from party platforms. [read post]
30 Sep 2022, 9:31 am by Kandace Watson
Kandace Watson, Corporate M&A Partner, Sheppard Mullin, and Michael-Bryant Hicks, a seasoned EVP, General Counsel & Corporate Secretary recently discussed mergers and acquisitions perspectives from the Boardroom and C-Suite. [read post]
7 Jun 2021, 6:05 am by Michael Geist
Credits: Question Period, House of Commons, June 4, 2021 The post The Law Bytes Podcast, Episode 91: “This is No Way to Regulate” – Former CRTC Chair Konrad von Finckenstein Speaks Out on the CRTC and Bill C-10 appeared first on Michael Geist. [read post]
18 Feb 2018, 8:52 am by Lawrence B. Ebert
It acquired its blockbuster hepatitis C drug, Sovaldi, by paying $11 billion for the drug's developer, Pharmasset, in 2011. (...)Gilead rationalized the price by noting that the near-term cure of hepatitis C meant even greater savings over time from a reduction in liver disease; but that was cold comfort to public budget makers and private insurers. [read post]
13 Sep 2022, 7:07 am by Michael Geist
The post The Bill C-11 Hearings Are Back, Part Two: The Risks to Canadian Creators appeared first on Michael Geist. [read post]